Abstract
Exposure to an ever-increasing number of man-made and natural environmental substances poses a health risk for the exposed individuals. To formulate public policy in order to protect the human population from the adverse effects of these agents, society needs first to gain an understanding of the mechanisms by which toxic agents compromise human health. In environmental health studies, the evaluation of risk results from a complex interplay of factors, including not only scientific components, but also socio-economic, ethical, legal, and geographical. As one of these scientific aspects, molecular biology has become an essential tool for the environmental toxicologist, because the rapidly-expanding advances in our understanding of biological processes at the molecular level have made it possible today to analyze problems that twenty years ago we could not even imagine existed. For example, the technology is now available to answer one of the most challenging questions that toxicologists face, namely: Are there genes that contribute to increased resistance (or sensitivity) to toxic environmental agents? Of course, the ultimate goal in this area of risk evaluation is not only to identify these genes, but to develop an understanding of how they function and how they affect human health; this is an eminently feasible goal with our current level of knowledge, given time and adequate resources. As more molecular biologists become attracted to the present challenges of toxicological research, we cannot but expect that many novel advances in molecular biology will be the result of our specific experimental demands, with the consequent opening of unpredictable new frontiers in environmental health research.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Levy, G. N., Martell, K. J., DeLeon, J. H., and Weber, W. W., 1992, Metabolic, molecular genetic and toxicological aspects of the acetylation polymorphism in inbred mice. Pharmacogenetics 2: 197–206.
Juberg, D. R., Bond, J.T., and Weber, W. W, 1991, N-acetylation of aromatic amines: Genetic polymorphism in inbred rat strains. Pharmacogenetics 1: 50–57.
Nebert, D. W., 1991, Polymorphism of human CYP2D genes involved in drug metabolism: possible relationship to individual cancer risk. Cancer Cells 3: 93–96.
Nebert, D. W., 1991, Role of genetics and drug metabolism in human cancer risk. Mut. Res. 247: 267–281.
Meyer, U. A., 1994, The molecular basis of genetic polymorphisms of drug metabolism. J Pharm. Pharmacol. 46: 409–415.
Coutts, R. T., 1994, Polymorphism in the metabolism of drugs, including antidepressant drugs: Comments on phenotyping. J. Psych. Neuros. 19: 30–44.
Winchester, R., 1994, The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56: 389–466.
Furlong, C. E., Costa, L. G., Hassett, C, Richter, R. J., Sundstrom, J. A., Adler, D. A., Disteche, C. M., Omiecinski, C. J., Chapline, C., and Crabb, J. W., 1993, Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem. Biol. Interact. 87: 35–48.
Daly, A. K., Cholerton, S., Gregory, W., and Idle, J. R., 1993, Metabolic polymorphisms. Pharmacol. Then 57: 129–160.
Idle, J. R., 1991, Is environmental carcinogenesis modulated by host polymorphism?. Mut. Res. 247: 259–266.
Pizzuti, A., Friedman, D. L., and Caskey, C. T., 1993, The myotonic dystrophy gene. Arch. Neurol. 50: 1173–1179.
Tuck-Muller, C. M., Martinez, J. E., Batista, D. A., Kearns, W. G., and Wertelecki, W., 1993, Duplication of the short arm of the X chromosome in mother and daughter. Hum. Genet. 91: 395–400.
Ross, C. A., Mclnnis, M. G., Margolis, R. L., and Li, S. H., 1993, Genes with triplet repeats: Candidate mediators of neuropsychiatric disorders. Trends Neurose. 16: 254–260.
Curtis, D., 1994 Another procedure for the preliminary ordering of loci based on two point lod scores. Ann. Hum. Genetics 58: 65–75.
Hildebrandt, F., Pohlmann, A., and Omran, H., 1993, LODVIEW: a computer program for the graphical evaluation of lod score results in exclusion mapping of human disease genes. Comp. Biomed. Res. 26: 592–599.
Lewis, C. M., and Cannings, C., 1992, The number of loci needed for ELOD calculations. Ann. Hum. Genetics 56: 59–69.
Collins, A. and Morton, N. E., 1991, Significance of maximal lods. Ann. Hum. Genetics 55: 39–41.
Risch, N., 1992, Genetic linkage: interpreting lod scores. Science 255: 803–804.
Schork, N. J., Boehnke, M., Terwilliger, J. D., and Ott, J. 1993, Two-trait-locus linkage analysis: A powerful strategy for mapping complex genetic traits. Am. J. Hum. Genet. 53: 1127–1136.
Terwilliger, J. D., Speer, M., and Ott, J., 1993, Chromosome-based method for rapid computer simulation in human genetic linkage analysis. Genet. Epidemiol. 10: 217–224.
Terwilliger, J. D., and Ott, J. 1993, A novel polylocus method for linkage analysis using the lod-score or affected sib-pair method. Genet. Epidemiol. 10: 477–482.
Ott, J., 1992, The future of multilocus linkage analysis. Ann. Medicine 24: 401–403.
Keats, B. J., Sherman, S. L., Morton, N. E., Robson, E. B., Buetow, K. H., Cartwright, P. E., Chakravarti, A., Francke, U., Green, P. P., and Ott, J., 1991, Guidelines for human linkage maps. An International System for Human Linkage Maps (ISLM, 1990). Ann. Hum. Genetics 55: 1–6.
Rodrigues, N. R., Cornall, R. J., Chandler, P., Simpson, E., Wicker, L. S., Peterson, L. B., and Todd, J. A., 1994, Mapping of an insulin-dependent diabetes locus, Idd9, in NOD mice to chromosome 4. Mammalian Genome 5: 167–170.
Landers, J. P., and Bunce, N. J., 1991, The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276: 273–287.
Nebert, D. W., Benedict, W. F., and Kouri, R. E., 1974, Aromatic hydrocarbon-produced tumorigenesis and the genetic differences in aryl hydrocarbon hydroxylase induction. In: Chemical Carcinogenesis (Ts’o, P. O. P., and DiPaolo, J. A., Eds.), pp.271–289. Marcel Dekker, New Yo
Nebert, D. W., Petersen, D. D., and Puga, A., 1991, Human AH locus polymorphism and cancer: inducibility of CYP1AI and other genes by combustion products and dioxin. Pharmacogenetics 1: 68–78.
Swanson, H. I., and Bradfield, C. A., 1993, The AH-receptor: genetics, structure and function. Pharmacogenetics 3: 213–230.
Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., and Bradfield, C. A., 1993, Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44: 911–917.
Le Beau, M. M., Carver, L. A., Espinosa, R., 3rd, Schmidt, J. V., and Bradfield, C. A., 1994, Chromosomal localization of the human AHR locus encoding the structural gene for the Ah receptor to 7p21-p15. Cytogenet. Cell. Genetics 66: 172–176.
Nebert, D. W., 1989, The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20: 153–174.
Greenlee, W. F., and Neal, R. A., 1985, The Ah receptor: a biochemical and biological perspective. In: The Receptors. (Conn, P. M., Ed.), pp.89–129. Academic Press, Inc. New York.
Whitlock. J. P., Jr., 1991, Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Ann Rev. Pharmacol. Toxicol. 30: 251–277.
Bauer, D., Muller, H., Reich, J., Riedel, H., Ahrenkiel, V., Warthoe, P., and Strauss, M., 1993, Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nue. Acids Res. 21: 4272–4280.
Liang, P., Averboukh. L., and Pardee, A. B., 1993, Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nuc. Acids Res. 21: 3269–3275.
Liang, P., Averboukh, L., Keyomarsi, K., Sager, R., and Pardee, A. B., 1992, Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52: 6966–6968.
Liang, P., and Pardee, A. B., 1992, Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967–971.
Askew, G. R., Doetschman, T., and Lingrel, J. B., 1993, Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol. Cell. Biol. 13: 4115–4124.
Doetschman, T. C., 1991, Gene targeting in embryonic stem cells. Biotechnology 16: 89–101.
Adams, D.E., Bliska, J.B., and Cozzarelli, N.R., 1992, Cre-lox recombination in Escherichia coli cells. Mechanistic differences from the in vitro reaction. J. Mol. Biol. 226: 661–673.
Sternberg, N., 1990, Bacteriophage PI cloning system for the isolation, amplification, and recovery of DNA fragments as large as 100 kilobase pairs. Proc. Natl. Acad. Sci. USA 87: 103–107.
Lakso, M., Sauer, B., Mosinger, B., Jr., Lee, E. J., Manning, R. W., Yu, S. H., Mulder, K. L., and Westphal, H., 1992, Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89: 6232–6236.
Baubonis, W., and Sauer, B., 1993, Genomic targeting with purified Cre recombinase. Nucl. Acids Res. 21: 2025–2029.
Sauer, B., 1993, Manipulation of transgenes by site-specific recombination: Use of Cre recombinase. Methods Enzymol. 225: 890–900.
Orban, P. C., Chui, D., and Marth, J. D., 1992, Tissue-and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89: 6861–6865.
Sauer, B., and Henderson, N., 1990, Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biologist 2: 441–449.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Puga, A., Micka, J., Chang, Cy., Liang, Hc., Nebert, D.W. (1996). Role of Molecular Biology in Risk Assessment. In: Snyder, R., et al. Biological Reactive Intermediates V. Advances in Experimental Medicine and Biology, vol 387. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9480-9_48
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9480-9_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9482-3
Online ISBN: 978-1-4757-9480-9
eBook Packages: Springer Book Archive